Skip to main content
Have a personal or library account? Click to login
One-year mortality in patients with pulmonary hypertension undergoing TAVI: a systematic review and descriptive meta-analysis Cover

One-year mortality in patients with pulmonary hypertension undergoing TAVI: a systematic review and descriptive meta-analysis

Open Access
|Aug 2026

References

  1. Ben-Dor I, et al. Pulmonary hypertension in patients undergoing transcatheter aortic valve implantation: a single-center experience. Catheter Cardiovasc Interv. 2011;78(1):136–143.
  2. Luçon A, Oger E, Bedossa M, Boulmier D, Verhoye JP, Eltchaninoff H, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 registry. Circ Cardiovasc Interv. 2014;7(5):624–632. doi:10.1161/CIRCINTERVENTIONS.113.000482.
  3. Lindman BR, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a PARTNER I trial substudy. Circ Cardiovasc Interv. 2015;8(3):e001961.
  4. Schewel J, et al. Invasive pulmonary hypertension and outcome after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015;8(11):1488–1497.
  5. D’Ascenzo F, et al. Pulmonary hypertension and transcatheter aortic valve implantation: a meta-analysis. Am J Cardiol. 2015;116(11):1774–1780.
  6. Testa L, Latib A, De Marco F, De Carlo M, Fiorina C, Montone R, et al. Persistence of severe pulmonary hypertension after transcatheter aortic valve replacement: incidence and prognostic impact. Circ Cardiovasc Interv. 2016;9(1):e003563. doi:10.1161/CIRCINTERVENTIONS.115.003563.
  7. Bishu K, et al. Pulmonary hypertension in patients undergoing transcatheter aortic valve replacement: prevalence and impact on outcomes. Am J Cardiol. 2014;114(10):1583–1589.
  8. Alushi B, et al. Prognostic impact of invasively assessed pulmonary hypertension in patients undergoing transcatheter aortic valve implantation. J Am Heart Assoc. 2019;8(11):e011681.
  9. Rodés-Cabau J, et al. Incidence, predictors, and prognostic value of pulmonary hypertension in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2010;105(10):1470–1476.
  10. Miyamoto J, et al. Impact of periprocedural pulmonary hypertension on outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2022;15(17):1775–1787.
  11. Boxhammer E, et al. Sex-specific outcomes in patients with pulmonary hypertension undergoing transcatheter aortic valve implantation. Eur Heart J. 2024;ehae666.2235.
  12. Khalil S, Tabowei G, Kaur M, Dadzie SK, Kansakar S, Moqattash M, et al. Effect of pulmonary hypertension on survival outcomes in patients with transcatheter aortic valve replacement: a systematic review and meta-analysis. Cureus. 2024;16(6):e62013. doi:10.7759/cureus.58540.
  13. Tang GH, et al. Prognostic value of pulmonary hypertension in patients undergoing transcatheter aortic valve implantation: a meta-analysis. J Am Heart Assoc. 2017;6(5):e005234.
  14. Desai R, et al. Pulmonary hypertension in transcatheter aortic valve replacement: a narrative review. J Clin Med. 2023;12(15):5032.
  15. Meybodi AM, et al. Prognostic impact of pulmonary hypertension in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. J Am Coll Cardiol. 2024;83(10):990–1002.
  16. Lee HW, et al. Changes in pulmonary hypertension following transcatheter aortic valve implantation and clinical outcomes. J Clin Med. 2025;14(1):101.
  17. Sinning JM, et al. Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement. EuroIntervention. 2015;11(4):415–423.
  18. Alwan L, et al. Impact of right ventricular-pulmonary arterial coupling on outcomes after transcatheter aortic valve implantation. J Am Coll Cardiol. 2023;81(11):1083–1094.
  19. Ruan Y, et al. Effect of pulmonary hypertension on the prognosis of patients undergoing transcatheter aortic valve replacement: a meta-analysis. Front Cardiovasc Med. 2025;12;1403061.
  20. Cardaioli F, et al. Updated definition of pulmonary hypertension and its impact on outcomes after TAVI. Heart. 2024;110(1);27–34.
  21. Masri A, Abdelkarim I, Sharbaugh MS, Althouse AD, Xu J, Han W, et al. Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement. Heart. 2018;104(10):821–827. doi:10.1136/heartjnl-2017-311978.
DOI: https://doi.org/10.2478/rjc-2026-0019 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Language: English
Published on: Aug 7, 2026
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Haytham Emara, Nadia Emara, Aigerim Sadykova, Ali Hammoud, Shady Emara, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.